CINCINNATI--(BUSINESS WIRE)--May 21, 2018--
Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of
10 directors at the Company’s 2018 annual shareholders’ meeting. Each of
the directors continues from the prior term.

Shareholders ratified the continuation of PricewaterhouseCoopers LLP as
the Company’s independent accountants for 2018. Shareholders also
approved Chemed’s executive compensation and the 2018 Stock Incentive
Plan. In addition, shareholders voted in favor of management’s
recommendation to reject the shareholder proposal to amend the Company’s
current proxy access bylaws.

Dividend Declared

Following the shareholders’ meeting, Chemed’s Board of Directors
declared a quarterly cash dividend of 28 cents per share on the
Company’s capital stock, payable on June 20, 2018, to shareholders of
record as of May 31, 2018. This represents the 188th consecutive
quarterly dividend paid to shareholders in Chemed’s 47 years as a public
company.

Listed on the New York Stock Exchange and headquartered in Cincinnati,
Ohio, Chemed Corporation (www.chemed.com)
operates two wholly owned subsidiaries: VITAS Healthcare and
Roto-Rooter. VITAS is the nation's largest provider of end-of-life
hospice care, and Roto-Rooter is the nation’s leading provider of
plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications
may relate to future events or Chemed's future performance.Such
statements are forward-looking statements and are based on present
information Chemed has related to its existing business circumstances.Investors are cautioned that such forward-looking statements are
subject to inherent risk and that actual results may differ materially
from such forward-looking statements.Further, investors are
cautioned that Chemed does not assume any obligation to update
forward-looking statements based on unanticipated events or changed
expectations.